Tone-dependent vasodilator responses to proadrenomedullin NH2-terminal 20 peptide in the hindquarters vascular bed of the rat

Peptides

Volumn 18, Issue 4, 1997, Pages 513-519

  Champion, H C ^a   Czapla, M A ^a   Friedman, D E ^a   Lambert, D G ^a   Murphy, W A ^a   Coy, D H ^a   Kadowitz, P J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic nervous system; Adrenomedullin (ADM); Proadrenomedullin NH2 terminal 20 peptide (PAMP); Tone dependent vasodilator responses

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADRENOMEDULLIN; ALPHA ADRENERGIC RECEPTOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROTEIN PRECURSOR;

ADRENERGIC NERVE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; NERVE ENDING; NONHUMAN; PERFUSION PRESSURE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; HINDLIMB; MUSCLE TONUS; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PEPTIDES; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASODILATOR AGENTS;

ANIMALIA;

EID: 0030906809     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00348-8     Document Type: Article

References (23)

1. 2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat. Peptides. 17:1996;1379-1387.
2. Champion H. C., Santiago J. A., Murphy W. A., Coy D. H., Kadowitz P. J. Adrenomedullin (2-2) antagonizes vasodilator responses to calcitonin gene-related peptide but not adrenomedullin in the cat. Am. J. Physiol. 271:1997;R234-242.
3. Feng C. J., Kang B., Kaye A. D., Kadowitz P. J., Nossaman B. D. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci. 55:1994;PL433-PL438.
4. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
5. Ishimitsu T., Nishikimi T., Saito Y., Kitamura K., Eto T., Kangawa K., Matsuo H., Omae T., Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 94:1994;2158-2161.
6. Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minamino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200:1994;642-646.
7. Jougasaki M., Rodeheffer R. J., Redfield M. M., Yamamoto K., Wei C., McKinley L. J., Burnett J. C. Cardiac secretion of adrenomedullin in human heart failure. J. Clin. Invest. 97:1996;2370-2376.
8. Jougasaki M., Wei C. M., Aarhus L. L., Heublein D. M., Sandberg S. M., Burnett J. C. Renal localization and actions of adrenomedullin: A natriuretic peptide. Am. J. Physiol. 268:1995;F657-F663.
9. Jougasaki M., Wei C., McKinley L. J., Burnett J. C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 92:1995;286-289.
10. Kitamura K., Kangawa K., Ishiyama Y., Washimine H., Ichiki Y., Kawamoto M., Minamino N., Matsuo H., Eto T. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide. FEBS Lett. 351:1994;3-7.
11. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
12. Kitamura K., Kangawa K., Kojima M., Ichiki Y., Matsuo H., Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursors. FEBS Lett. 338:1994;306-310.
13. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
14. Kohno M., Hanehira T., Kano H., Horio T., Yokokawa K., Ikeda M., Minami M., Yasunari K., Yoshikawa J. Plasma adrenomedullin concentrations in essential hypertension. Hypertension. 27:1996;102-107.
15. Kuwasako K., Kitamura K., Ichiki Y., Kato J., Kangawa K., Matsuo H., Eto T. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Biochem. Biophys. Res. Commun. 211:1995;694-699.
16. Majid D. S. A., Kadowitz P. J., Coy D. H., Navar L. G. Renal responses to intraarterial administration of adrenomedullin in dogs. Am. J. Physiol. 270:1996;F200-F205.
17. Nossaman B. D., Feng C. J., Kaye A. D., DeWitt B. J., Coy D. H., Murphy W. A., Kadowitz P. J. Pulmonary vasodilator responses to adrenomedullin are reduced by nitric oxide synthetase inhibitors in the rat but not in the cat. Am. J. Physiol. 270:1996;L782-L789.
18. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:1993;921-927.
19. Shimosawa T., Fujita T. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension. 28:1996;325-329.
20. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J. Clin. Invest. 96:1995;1672-1676.
21. Vari R. C., Adkins S. D., Samson W. K. Renal effects of adrenomedullin in the rat. Proc. Soc. Exp. Biol. Med. 211:1995;178-183.
22. Snedecor, G. W.; Cochran, W. G. Statistical Methods (6th Ed.). Ames:Iowa State University Press, pp. 258-338; 1967.
23. Washimine H., Kitamura K., Ichiki Y., Yamamoto Y., Kangawa K., Matsuo H., Eto T. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem. Biophys. Res. Commun. 202:1994;1081-1087.